RxDoctor Payments Data

Douglas Burton, MD

Orthopaedic Surgery of the Spine · Kansas City, KSNPI 1194834168

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Globus Medical accounts for 80.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $13,016 and has fallen 98.3% since, to $221 in 2025.

$43,143in general payments, 2019–2025

Across 84 payments — averaging $513.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$35K
  • Medical Device Business Services, Inc.$5K
  • Depuy Synthes Products, Inc.$2K
  • Medtronic$808
  • Alphatec Spine, Inc$300
  • Johnson & Johnson$292
  • plus $308 from 2 others
$148,747in research payments, 2019–2025

Across 11 payments — averaging $13,522 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$78K
  • Medical Device Business Services, Inc.$68K
  • Bioventus LLC$3K

What the payments were for

  • Royalty or licence$1,4653%
  • Consulting fees$22,81553%
  • Speaking & faculty fees$6,00014%
  • Travel & lodging$9,50622%
  • Food & beverage$3,3578%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$15,957
Medicare patients
144
Services billed
175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery of the spine in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →